Skip to content
AstraZeneca receives US FDA approval for Koselugo in adults with NF1
Home - Spotlight - AstraZeneca receives US FDA approval for Koselugo in adults with NF1
- admin
- November 20, 2025
- Latest Update: November 20, 2025 1:44 pm
- 12
- Less than a minute
- 0
Read Full